Cargando…

Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67

INTRODUCTION: Triple-negative breast cancer (TNBC), which is characterized by negativity for estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 (HER2), is a high risk breast cancer that lacks specific targets for treatment selection. Chemotherapy is, therefore, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kashiwagi, Shinichiro, Yashiro, Masakazu, Takashima, Tsutomu, Aomatsu, Naoki, Ikeda, Katsumi, Ogawa, Yoshinari, Ishikawa, Tetsuro, Hirakawa, Kosei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326564/ https://www.ncbi.nlm.nih.gov/pubmed/22126395 http://dx.doi.org/10.1186/bcr3068

Ejemplares similares

CD133 Is a Useful Surrogate Marker for Predicting Chemosensitivity to Neoadjuvant Chemotherapy in Breast Cancer
por: Aomatsu, Naoki, et al.
Publicado: (2012)

Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline
por: Aomatsu, Naoki, et al.
Publicado: (2014)

Relationship between serum lipid levels and the immune microenvironment in breast cancer patients: a retrospective study
por: Goto, Wataru, et al.
Publicado: (2022)

Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer
por: KAWAJIRI, HIDEMI, et al.
Publicado: (2014)

Laparoscopic Adrenalectomy in a Patient with Situs Inversus
por: Kashiwagi, Shinichiro, et al.
Publicado: (2013)

Significance of E-cadherin expression in triple-negative breast cancer
por: Kashiwagi, S, et al.
Publicado: (2010)

A rare recurrence of bilateral breast cancer in the esophagus coincidentally associated with primary gastric cancer: a case report
por: Kashiwagi, Shinichiro, et al.
Publicado: (2014)

Mammary phyllodes tumor with six episodes of a relapse: a case report
por: Iimori, Nozomi, et al.
Publicado: (2017)

A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancer
por: Takashima, Tsutomu, et al.
Publicado: (2016)

Reactive lymphoid hyperplasia of the thyroid followed by systemic autoimmune diseases: a case report
por: Onoda, Naoyoshi, et al.
Publicado: (2014)

Hypoxia Stimulates the EMT of Gastric Cancer Cells through Autocrine TGFβ Signaling
por: Matsuoka, Junko, et al.
Publicado: (2013)

Expression of E-cadherin and KRAS mutation may serve as biomarkers of cetuximab-based therapy in metastatic colorectal cancer
por: NAKAMOTO, KENTARO, et al.
Publicado: (2013)

Adrenal Schwannoma Treated With Laparoscopic Surgery
por: Onoda, Naoyoshi, et al.
Publicado: (2008)

Alveolar soft part sarcoma metastatic to the breast: a case report
por: Asano, Yuka, et al.
Publicado: (2019)

Cowden Syndrome Diagnosed by Bilateral Breast Cancer with Lhermitte-Duclos Disease: A Case Report
por: Morisaki, Tamami, et al.
Publicado: (2020)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Expression of E-cadherin, Ki-67, and p53 in urinary bladder cancer in relation to progression, survival, and recurrence
por: Ziaran, Stanislav, et al.
Publicado: (2020)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Mutations in TGFbeta-RII and BAX mediate tumor progression in the later stages of colorectal cancer with microsatellite instability
por: Yashiro, Masakazu, et al.
Publicado: (2010)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma
por: Kashiwagi, Shinichiro, et al.
Publicado: (2013)

Adjunctive imprint cytology of core needle biopsy specimens improved diagnostic accuracy for breast cancer
por: Kashiwagi, Shinichiro, et al.
Publicado: (2013)

Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer
por: Asano, Yuka, et al.
Publicado: (2015)

Partial mastectomy using manual blunt dissection (MBD) in early breast cancer
por: Kashiwagi, Shinichiro, et al.
Publicado: (2015)

Platelet–Lymphocyte Ratio as a Useful Predictor of the Therapeutic Effect of Neoadjuvant Chemotherapy in Breast Cancer
por: Asano, Yuka, et al.
Publicado: (2016)

IgG4-related mastitis requiring differentiation from breast cancer: a case report
por: Asano, Yuka, et al.
Publicado: (2021)

Proliferation Marker Ki67 as a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal Melanoma
por: Tang, Lirui, et al.
Publicado: (2022)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

ICAM‐1 (Intercellular Adhesion Molecule‐1) Gene Transfection Inhibits Lymph Node Metastasis by Human Gastric Cancer Cells
por: Sunami, Takeshi, et al.
Publicado: (2000)

Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas
por: Nowak, Marcin, et al.
Publicado: (2016)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
por: Horimoto, Yoshiya, et al.
Publicado: (2014)

Ambulatory sentinel lymph node biopsy preceding neoadjuvant therapy in patients with operable breast cancer: a preliminary study
por: Kashiwagi, Shinichiro, et al.
Publicado: (2015)

Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer
por: Asano, Yuka, et al.
Publicado: (2016)

Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer
por: Takada, Koji, et al.
Publicado: (2018)

Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer
por: Takada, Koji, et al.
Publicado: (2018)

Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy
por: Goto, Wataru, et al.
Publicado: (2018)

Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer
por: Takada, Koji, et al.
Publicado: (2019)

Pure Mucinous Breast Carcinoma with Micropapillary Pattern (MUMPC): A Case Report
por: Asano, Yuka, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eo5kvqouuiufar20m08nhn8euu